Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
11.4 %
$ 3.32 B
Market Cap
-29.26
P/E
VKTX - NET CHANGE IN CASH
Net Change in Cash VKTX - Viking Therapeutics, Inc.
18.9 M
LAST VALUE
197.94%
2 YEAR CAGR
3.64%
5 YEAR CAGR
59.28%
10 YEAR CAGR